Gontinias, Excelsia B.

HRN: 00-26-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/21/2025
08/28/2025
IVTT
500mg
Q8H
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines